Pulmonary fibrosis biotech Avalyn Pharma files for a $100 million IPO April 30, 2026 News Pulmonary fibrosis biotech Avalyn Pharma prices upsized IPO at $18, the high end of the range Avalyn Pharma, a Phase 2 biotech developing inhaled medicines... Read more
Hong Kong restaurant operator CSC Collective Holdings triples shares offered ahead of $20 million US IPO IPO Overview CSC Collective Holdings, which operates two high-end Japanese-style restaurants in Hong Kong, raised the proposed deal size for its upcoming IPO on... Read more
Defense electronics manufacturer Arxis sets terms for $1 billion IPO April 15, 2026 News Defense electronics manufacturer Arxis prices upsized IPO at $28, the high end of the range Arxis, an aerospace and defense electronics and components manufacturer, raised $1.1... Read more